Skip to Content

Join the 'Anesthetic Adjunct' group to help and get support from people like you.

Anesthetic Adjunct News

Anesthesia Safe for Infants, Toddlers, Study Says

Posted 7 Jun 2016 by Drugs.com

TUESDAY, June 7, 2016 – General anesthesia doesn't seem to harm young children's mental development, new research concludes. "A number of animal studies have suggested that exposure to commonly used anesthetic agents in early development could lead to deficits in learning, memory, attention and other cognitive functions," said study author Dr. Lena Sun. She is a professor of pediatric anesthesiology and pediatrics at Columbia University Medical Center in New York City. "However, few clinical studies have adequately addressed whether this is also true in humans," Sun said in a Columbia news release. The new study findings are "good news for parents whose children need anesthesia for elective surgery or a diagnostic procedure," she added. Still, the study leaves some important questions unanswered, Sun said. "We need to take a closer look at the effect of anesthesia on cognitive function ... Read more

Related support groups: Lidocaine, Anesthesia, Propofol, Ketamine, Xylocaine, Local Anesthesia, Bupivacaine, Marcaine, Diprivan, Novocain, Septocaine, Nitrous Oxide, Procaine, Prilocaine, Light Sedation, Sevoflurane, Mepivacaine, Tetracaine, Isoflurane, Halothane

FDA Medwatch Alert: Atracurium Besylate Injection by Sagent Pharmaceuticals: Recall - Potential Impact on Product Sterility

Posted 24 Feb 2015 by Drugs.com

ISSUE: Sagent Pharmaceuticals, Inc. announced the voluntary nationwide recall of two lots of Atracurium Besylate Injection, USP, 50mg/5mL single-dose vials (NDC 25021-659-05) and four lots of Atracurium Besylate Injection, USP, 100mg/10mL multi-dose vials (NDC 25021-672-10) manufactured by Emcure Pharmaceuticals Ltd. and distributed by Sagent. Sagent has initiated this voluntary recall of Atracurium Besylate Injection, USP, 50mg/5mL and 100mg/10mL to the user level due to FDA observations pertaining to aseptic and GMP practices at the manufacturer’s site potentially impacting product sterility. Non-sterility of a drug administered via the intravenous route has the potential to result in infections, which could be fatal, especially in patients who are immunocompromised. BACKGROUND: The lot numbers being recalled are VATA012, VATA015 (50mg/5mL) and VATB012, VATB013, VATB014, VATB017 ( ... Read more

Related support groups: Atracurium, Anesthetic Adjunct, Tracrium

FDA Medwatch Alert: Vecuronium Bromide For Injection by Sagent Pharmaceuticals, Inc.: Recall - Elevated Impurity Result Detected

Posted 11 Jun 2013 by Drugs.com

ISSUE: Sagent Pharmaceuticals, Inc. announced the voluntary nationwide recall of three lots of Vecuronium Bromide for Injection 10mg (NDC number 25021-657-10) manufactured by Mustafa Nevzat Ilac Sanayii A.S. (MN Pharmaceuticals) and distributed by Sagent.  Sagent has initiated this voluntary recall of Vecuronium Bromide for Injection to the user level due to the  discovery of an elevated impurity result detected during routine quality testing of stability samples at the 18-month interval. The elevated impurity result has the potential to result in prolonged neuromuscular blockade for critically ill patients with renal failure.  BACKGROUND: Vecuronium Bromide for Injection is a neuromuscular blocking agent indicated as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation and is supplied i ... Read more

Related support groups: Anesthesia, Vecuronium, Anesthetic Adjunct, Norcuron

Ask a Question

Further Information

Related Condition Support Groups

Anesthesia

Related Drug Support Groups

fentanyl, hydromorphone, Stadol, butorphanol, Palladone, Pentothal, Dilaudid-HP, atracurium, thiopental, Tracrium, Sublimaze, methohexital, Brevital Sodium